In this issue:
Maintenance olaparib confers long-term PFS benefit in advanced disease
Prevalence of germline BRCA1/2 mutations in histological subtypes
Pre-existing TP53 CHIP variants may predispose OC patients to secondary MNs
High concordance of BRCA mutation detection in tumour and blood
Breast cancer surveillance in BRCA-associated epithelial OC
NACT is an appropriate front-line strategy for many patients with advanced OC
Single dose of quadrivalent HPV vaccine highly efficacious
Radiotherapy may be a safer therapy to IFL for vulvar micrometastases
Laparoscopic interval cytoreduction feasible for advanced OC
Menopause-related symptoms after premenopausal risk-reducing salpingo-oophorectomy
Please login below to download this issue (PDF)